Loading...
Pfizer Inc.
PFE•NYSE
Healthcare
Drug Manufacturers - General
$24.41
$-0.14(-0.55%)
Pfizer Inc. (PFE) Financial Performance & Statements
Review Pfizer Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
8.77%
↑ 8.77%
Operating Income Growth
344.72%
↑ 344.72%
Net Income Growth
279.00%
↑ 279.00%
Operating Cash Flow Growth
46.48%
↑ 46.48%
Operating Margin
23.65%
↑ 23.65%
Gross Margin
67.39%
↑ 67.39%
Net Profit Margin
12.59%
↑ 12.59%
ROE
8.78%
↑ 8.78%
ROIC
8.61%
↑ 8.61%
Pfizer Inc. (PFE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Pfizer Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $17.76B | $17.70B | $13.28B | $14.88B |
| Cost of Revenue | $5.91B | $6.58B | $5.04B | $4.38B |
| Gross Profit | $11.85B | $11.13B | $8.24B | $10.50B |
| Gross Profit Ratio | $0.67 | $0.63 | $0.62 | $0.71 |
| R&D Expenses | $3.04B | $2.60B | $2.68B | $2.48B |
| SG&A Expenses | $4.27B | $3.24B | $3.69B | $3.46B |
| Operating Expenses | $8.67B | $5.84B | $6.36B | $5.94B |
| Total Costs & Expenses | $13.36B | $12.42B | $11.40B | $10.32B |
| Interest Income | $170.00M | $116.00M | $130.00M | $129.00M |
| Interest Expense | $739.00M | $783.00M | $778.00M | $790.00M |
| Depreciation & Amortization | $1.79B | $1.75B | $1.73B | $1.74B |
| EBITDA | $2.52B | $7.25B | $2.40B | $5.95B |
| EBITDA Ratio | $0.14 | $0.41 | $0.18 | $0.40 |
| Operating Income | $3.19B | $5.28B | $1.88B | $4.56B |
| Operating Income Ratio | $0.18 | $0.30 | $0.14 | $0.31 |
| Other Income/Expenses (Net) | -$3.20B | -$569.00M | -$1.98B | -$1.14B |
| Income Before Tax | -$10.00M | $4.71B | -$103.00M | $3.42B |
| Income Before Tax Ratio | -$0.001 | $0.27 | -$0.008 | $0.23 |
| Income Tax Expense | -$421.00M | $234.00M | -$134.00M | $293.00M |
| Net Income | $410.00M | $4.46B | $24.00M | $3.12B |
| Net Income Ratio | $0.02 | $0.25 | $0.002 | $0.21 |
| EPS | $0.07 | $0.79 | $0.004 | $0.55 |
| Diluted EPS | $0.07 | $0.78 | $0.004 | $0.55 |
| Weighted Avg Shares Outstanding | $5.67B | $5.67B | $5.67B | $5.66B |
| Weighted Avg Shares Outstanding (Diluted) | $5.70B | $5.71B | $5.70B | $5.70B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan